Saturday, September 23, 2023
Saturday, September 23, 2023

MCRA Assists Multiple Clients with Successfully Obtaining CPT Codes & Hospital Payment Reassignments

MCRA, LLC a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory Affairs, Clinical Trial Operations, Reimbursement and Market Access, Healthcare Compliance, Cybersecurity, and Quality Assurance support is pleased to announce its involvement with successfully obtaining several new CPT codes and payment reassignments on behalf of numerous clients.

Prior to the publication of the rules, MCRA worked with CMS to establish appropriate payment assignment for several clients and received validation of the decisions with the publication of the Final CY 2022 Payment Rules for Medicare Hospital and Physician Payments on November 2, 2021.

In addition, following the September CPT Coding Editorial Panel meeting the AMA published its final decisions validating that MCRA successfully collaborated with its clients and with relevant specialty societies to establish several Category III CPT codes as well as a Category I CPT code, the latter of which required stringent publication requirements and robust utilization data.

Vincent Lesniewski, Senior Director, Market Access, at Centinel Spine said, “Through our collaboration with and guidance from the MCRA reimbursement team, we are pleased to report a successful panel meeting and the issuance of a permanent CPT code that will allow providers to report use of the prodiscL™ technology at two levels”.

Debbie Garner, Co-CEO, of FemSelect said, “We are thrilled with the outcome of our work with the MCRA team to establish appropriate hospital outpatient and ASC payment assignment, allowing for women who suffer from the symptoms of pelvic organ prolapse to access the EnPlace technology.”

Nestor Jaramillo, President and CEO, of Nuwellis said, “With the help of MCRA’s Reimbursement team, Ultrafiltration with Aquadex has realized key reimbursement milestones in 2021, with the successful assignment of a CPT code and a payment assignment in the hospital outpatient setting.”

Tonya Dowd, MCRA’s Vice President of Reimbursement Health Economics and Market Access said, “Establishing new coding mechanisms and appropriate payment assignment is imperative to ensure market access for patients who can benefit from our clients’ innovative therapies.  We are delighted that our Reimbursement, Health Economics and Market Access team, collaborated well with the respective organizations to achieve this success for them.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy